Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model

Boris Gorelik, Irit Ziv, Revital Shohat, Michael Wick, W. David Hankins, David Sidransky, Zvia Agur

Open source

DOI
10.1158/0008-5472.can-08-1723
Published
2008-10-30
Container
Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-08-1723,
  title = {Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model},
  author = {Boris Gorelik and Irit Ziv and Revital Shohat and Michael Wick and W. David Hankins and David Sidransky and Zvia Agur},
  year = {2008},
  journal = {Cancer Research},
  doi = {10.1158/0008-5472.can-08-1723},
  url = {https://doi.org/10.1158/0008-5472.can-08-1723}
}

RIS

TY  - JOUR
TI  - Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model
AU  - Boris Gorelik
AU  - Irit Ziv
AU  - Revital Shohat
AU  - Michael Wick
AU  - W. David Hankins
AU  - David Sidransky
AU  - Zvia Agur
PY  - 2008
JO  - Cancer Research
DO  - 10.1158/0008-5472.can-08-1723
UR  - https://doi.org/10.1158/0008-5472.can-08-1723
ER  - 

APA

Gorelik, B., Ziv, I., Shohat, R., Wick, M., Hankins, W. D., Sidransky, D., & Agur, Z. (2008). Efficacy of Weekly Docetaxel and Bevacizumab in Mesenchymal Chondrosarcoma: A New Theranostic Method Combining Xenografted Biopsies with a Mathematical Model. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-1723

Source records